A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis

2011 ◽  
Vol 70 (6) ◽  
pp. 913-919 ◽  
Author(s):  
Amr Al-Saif ◽  
Futwan Al-Mohanna ◽  
Saeed Bohlega
2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Pin-Tse Lee ◽  
Jean-Charles Liévens ◽  
Shao-Ming Wang ◽  
Jian-Ying Chuang ◽  
Bilal Khalil ◽  
...  

ABSTRACT In a subgroup of patients with amyotrophic lateral sclerosis (ALS)/Frontotemporal dementia (FTD), the (G4C2)-RNA repeat expansion from C9orf72 chromosome binds to the Ran-activating protein (RanGAP) at the nuclear pore, resulting in nucleocytoplasmic transport deficit and accumulation of Ran in the cytosol. Here, we found that the sigma-1 receptor (Sig-1R), a molecular chaperone, reverses the pathological effects of (G4C2)-RNA repeats in cell lines and in Drosophila. The Sig-1R colocalizes with RanGAP and nuclear pore proteins (Nups) and stabilizes the latter. Interestingly, Sig-1Rs directly bind (G4C2)-RNA repeats. Overexpression of Sig-1Rs rescues, whereas the Sig-1R knockout exacerbates, the (G4C2)-RNA repeats-induced aberrant cytoplasmic accumulation of Ran. In Drosophila, Sig-1R (but not the Sig-1R-E102Q mutant) overexpression reverses eye necrosis, climbing deficit, and firing discharge caused by (G4C2)-RNA repeats. These results on a molecular chaperone at the nuclear pore suggest that Sig-1Rs may benefit patients with C9orf72 ALS/FTD by chaperoning the nuclear pore assembly and sponging away deleterious (G4C2)-RNA repeats.


Author(s):  
Mireia Herrando‐Grabulosa ◽  
Núria Gaja‐Capdevila ◽  
José M. Vela ◽  
Xavier Navarro

2015 ◽  
Vol 127 (1) ◽  
pp. 10-16 ◽  
Author(s):  
Timur A. Mavlyutov ◽  
Lian-Wang Guo ◽  
Miles L. Epstein ◽  
Arnold E. Ruoho

Author(s):  
Simon Couly ◽  
Bilal Khalil ◽  
Véronique Viguier ◽  
Julien Roussel ◽  
Tangui Maurice ◽  
...  

Abstract Sigma-1 receptor (S1R) is an endoplasmic reticulum (ER) chaperone that regulates mitochondrial respiration but also controls cellular defense against ER and oxidative stress. This makes S1R a potential therapeutic target in amyotrophic lateral sclerosis (ALS). Especially, as a missense mutation E102Q in S1R has been reported in few familial ALS cases. However, the pathogenicity of S1RE102Q and the beneficial impact of S1R in the ALS context remain to be demonstrated in vivo. To address this, we generated transgenic Drosophila that express human wild-type S1R or S1RE102Q. Expression of mutant S1R in fly neurons induces abnormal eye morphology and locomotor defects in a dose-dependent manner. This was accompanied by abnormal mitochondrial fragmentation, reduced ATP levels and a higher fatigability at the neuromuscular junction during high energy demand. Overexpressing IP3 receptor or glucose transporter mitigates the S1RE102Q-induced eye phenotype, further highlighting the role of calcium and energy metabolism in its toxicity. More importantly, we showed that wild-type S1R rescues locomotor activity and ATP levels of flies expressing the key ALS protein, TDP43. Moreover, overexpressing wild-type S1R enhances resistance of flies to oxidative stress. Therefore, our data provide the first genetic evidence that mutant S1R recapitulates ALS pathology in vivo while increasing S1R confers neuroprotection against TDP43 toxicity.


2014 ◽  
Vol 559 ◽  
pp. 174-178 ◽  
Author(s):  
Yoko Ono ◽  
Hirotaka Tanaka ◽  
Masafumi Takata ◽  
Yuki Nagahara ◽  
Yasuhiro Noda ◽  
...  

Brain ◽  
1990 ◽  
Vol 113 (2) ◽  
pp. 347-363 ◽  
Author(s):  
MONGI BEN HAMIDA ◽  
FAYÇAL HENTATI ◽  
CHRISTIANE BEN HAMIDA

2021 ◽  
Vol 429 ◽  
pp. 119387
Author(s):  
Giorgia Bruno ◽  
Francesco Barbato ◽  
Giovanni Colacicco ◽  
Domenico Ippolito ◽  
Antonio Di Masi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document